×
Science / Biology

Corifact

Published Feb 15 2022 at 3:05 PM GMT
FDA.gov

FDA.gov @fda.gov

Continue reading at fda.gov
Key
Points
  • Product approval information is indicated for the routine prophylactic treatment and the peri-operative management of surgical bleeding in adult and pediatric patients with Congenital Factor XIII deficiency.
Credit
Tags
Continue reading at fda.gov
Trending

Stats

  • Published Feb 15, 2022 3:05 PM GMT